Case I: 3DMed: An R&D Platform for Personalised Precision Anti-cancer Drugs

Xiaoming Zhu ()
Additional contact information
Xiaoming Zhu: China Europe International Business School

A chapter in China's Technology Innovators, 2018, pp 1-32 from Springer

Abstract: Abstract In 2010, Xiong Lei, a Ph.D. graduate from the Institute of Biochemistry and Cell Biology, SIBCB, CAS, left his post-doctoral research in the University of Zurich to found 3DMed with five other senior professionals, aiming to substantially improve R&D efficiency and approval rates of anti-cancer drugs and deliver highly effective clinical treatment for cancer. The new company is headquartered in the Shanghai Caohejing Hi-Tech Park, where over 140 biomedical start-ups are planning their business roadmaps. The question now is how 3DMed, which had completed two rounds of financing by May 2014, will achieve the expected performance and leverage talent, marketing and capital management, as well as strategic planning, to address the challenges it faces in the early stage of business development as well as to minimise innovation risks in an emerging industry.

Keywords: Anti-cancer Drugs; Personalised Precision; China Europe International Business School (CEIBS); Business Model Innovation; Precision Therapy (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:mgmchp:978-981-10-5388-7_1

Ordering information: This item can be ordered from
http://www.springer.com/9789811053887

DOI: 10.1007/978-981-10-5388-7_1

Access Statistics for this chapter

More chapters in Management for Professionals from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().